Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell D Hull

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Inferior vena cava filtersAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Treatment for patients with cancerAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Cost-effectiveness of prevention and treatment of VTEAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
The American Journal of Medicine|May 20, 2011
Increasing use of vena cava filters for prevention of pulmonary embolismPaul D Stein, Fadi Matta, Russell D Hull
Thrombosis and Haemostasis|October 17, 2007
Spiral computed tomography for the diagnosis of acute pulmonary embolismPaul D Stein, Fadi Kayali, Russell D Hull
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2009
State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxisRussell D Hull, Roger D Yusen, David Bergqvist
Clinics in Chest Medicine|November 5, 2010
Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopeniaRobert C Pendleton, George M Rodgers, Russell D Hull
The American Journal of Medicine|February 27, 2004
Lessening the diagnostic uncertainty in patients with suspected pulmonary embolismRussell D Hull, William A Ghali, Graham F Pineo
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 16, 2010
Contaminants in heparins: are all facts known?Jawed Fareed, Debra A Hoppensteadt, Eduardo Ramacciotti, et al.
Thrombosis and Haemostasis|October 25, 2013
Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic reviewRussell D Hull, Jane Liang, David Bergqvist, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Inferior vena cava filtersAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Treatment for patients with cancerAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 27, 2013
Cost-effectiveness of prevention and treatment of VTEAndrew Nicolaides, Russell D Hull, Jawed Fareed, et al.
The American Journal of Medicine|May 20, 2011
Increasing use of vena cava filters for prevention of pulmonary embolismPaul D Stein, Fadi Matta, Russell D Hull
Thrombosis and Haemostasis|October 17, 2007
Spiral computed tomography for the diagnosis of acute pulmonary embolismPaul D Stein, Fadi Kayali, Russell D Hull
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2009
State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxisRussell D Hull, Roger D Yusen, David Bergqvist
Clinics in Chest Medicine|November 5, 2010
Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopeniaRobert C Pendleton, George M Rodgers, Russell D Hull
The American Journal of Medicine|February 27, 2004
Lessening the diagnostic uncertainty in patients with suspected pulmonary embolismRussell D Hull, William A Ghali, Graham F Pineo
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 16, 2010
Contaminants in heparins: are all facts known?Jawed Fareed, Debra A Hoppensteadt, Eduardo Ramacciotti, et al.
Thrombosis and Haemostasis|October 25, 2013
Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic reviewRussell D Hull, Jane Liang, David Bergqvist, et al.
Pageof 13